JP Morgan Chase
VRXA

JP Morgan Chase’s Veraxa Biotech AG VRXA Stock Holding History

JP Morgan Chase’s Portfolio VRXA Stock Details VRXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$859 Buy
+396
New +$3.17K ﹤0.01% 7352

Other funds holding VRXA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.47% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

JP Morgan Chase's VRXA Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Veraxa Biotech AG (VRXA) in Q2 2026: 396 shares worth $859. The stake represents ﹤0.01% of the portfolio and ranks #7352 among its holdings.

6 funds tracked by Wall St. Rank hold VRXA as of Q2 2026.

  • JP Morgan Chase held 396 shares of Veraxa Biotech AG worth $859 as of Q2 2026.
  • Veraxa Biotech AG was a new JP Morgan Chase position in Q2 2026.
  • Veraxa Biotech AG made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7352 holding.
  • 6 funds tracked by Wall St. Rank held Veraxa Biotech AG as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.